The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $327,085 were sold by Fox Christine on Nov 20 ’24. At $16.87 per share, Fox Christine sold 19,388 shares. The insider’s holdings dropped to 44,104 shares worth approximately $0.73 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Fox Christine purchased 19,388 shares, netting a total of over 327,085 in proceeds.
Before that, Daniell Richard had sold 98,943 shares from its account. In a trade valued at $1,711,447, the Exec. VP, European Commercial traded Teva- Pharmaceutical Industries Ltd. ADR shares for $17.30 each. Upon closing the transaction, the insider’s holdings decreased to 98,943 shares, worth approximately $0.0.
As published in a research note from Argus on July 10, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from a Hold to a Buy and the price target has been revised to $20. Analysts at JP Morgan upgraded the stock from ‘”an Underweight”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of February 12, 2024, Piper Sandler has increased its “Neutral” rating to a “an Overweight” for TEVA. Earlier on January 23, 2024, Jefferies upgraded its rating. Their new recommendation was “a Buy” for TEVA stock which previously was a “a Hold”.
Analyzing TEVA Stock Performance
During the last five days, there has been a drop of approximately -2.70%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have jumped approximately 58.72%. Shares of the company reached a 52-week high of $19.31 on 11/06/24 and a 52-week low of $10.45 on 01/02/24. A 50-day SMA is recorded $17.59, while a 200-day SMA reached $16.23. Nevertheless, trading volume fell to 9.28 million shares from 13.08 million shares the previous day.
Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)
According to the 24-hour chart, there is a support level at 16.45, which, if violated, would cause prices to drop to 16.33. In the upper region, resistance lies at 16.69. The next price resistance is at 16.81. RSI (Relative Strength Index) is 37.44 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.25, which suggests the price will decrease in the coming days. Percent R is at 69.12%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
